KRAS and HRAS mutations confer resistance to MET targeting in preclinical models of MET-expressing tumor cells.
| Image |  |
|---|---|
| Description | scientific article published on 14 April 2015 |
| Author/s |
author: Lluís Nisa Michaela Medová |
| Publication date | April 14, 2015 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |